VIPDOMET is a prescription medication used in the management of type 2 diabetes mellitus. It is a combination drug that contains two active ingredients: vildagliptin and metformin. Vildagliptin belongs to a class of drugs known as dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by increasing the release of insulin from the pancreas and decreasing the release of glucagon, a hormone that raises blood sugar levels. Metformin, on the other hand, works by decreasing glucose production in the liver and improving the body's sensitivity to insulin. Together, these two components help to control blood sugar levels in adults with type 2 diabetes. VIPDOMET is typically prescribed when diet and exercise alone have not been enough to control blood glucose levels, and it may be used in combination with other diabetes medications as part of a comprehensive treatment plan.